![]() |
市场调查报告书
商品编码
1970739
宠物驱虫剂市场-全球产业规模、份额、趋势、机会与预测:按产品类型、宠物类型、应用、地区和竞争格局划分,2021-2031年Pet Insect Repellent Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product Type, By Pet Type, By Application, By Region & Competition, 2021-2031F |
||||||
全球宠物驱虫剂市场预计将从 2025 年的 34.1 亿美元成长到 2031 年的 44.5 亿美元,复合年增长率为 4.54%。
这些驱虫剂包括专门的口服或外用配方,例如喷雾剂、项圈和滴剂,旨在透过消除或驱避蚊子、蜱虫和跳蚤等体外寄生虫来保护伴侣动物。推动这一市场发展的主要因素是人与动物之间关係的日益密切,这促使饲主更加重视预防性护理,以降低通用感染疾病的风险。这种向日常保健支出增加的根本性转变意义重大。根据美国宠物用品协会 (APPA) 预测,到 2024 年,美国兽医支出和产品销售额将达到 398 亿美元。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 34.1亿美元 |
| 市场规模:2031年 | 44.5亿美元 |
| 复合年增长率:2026-2031年 | 4.54% |
| 成长最快的细分市场 | 局部治疗 |
| 最大的市场 | 北美洲 |
然而,阻碍市场显着成长的一大障碍是日益严格的环境安全和化学毒性法规环境。製造商必须遵守监管机构制定的复杂核准程序,这些机构会对活性成分对当地生态系统和动物健康的负面影响进行彻底调查。这些高标准的合规要求需要进行全面的安全测试,导致研发成本增加,并延缓符合法规要求的新型害虫防治产品的商业化。
气候变迁导致害虫栖息地扩张,加剧了疾病传播疾病的发生率,这是推动市场成长的主要动力。随着气温升高延长了蚊子、蜱虫和跳蚤的繁殖季节,宠物饲主越来越关注高效的预防措施,以保护他们的犬猫免受心丝虫病和莱姆病等严重的侵害。人们对环境威胁的意识提升,显着提高了强效抗寄生虫药物生产商的收入。例如,勃林格殷格翰于2024年4月发布的《2023年度报告》指出,其跳蚤和蜱虫控製品牌「NEXGARD」的销售额经外汇调整后增长了17.2%,达到12亿欧元,这表明消费者对可靠的预防保健有着强烈的依赖。
同时,全球宠物拥有率的上升以及宠物日益拟人化,正在扩大高品质健康产品的基本客群。随着饲主越来越将宠物视为家庭成员,对预防性照护的重视程度不断提高,购买先进且便利的驱虫产品的意愿也随之增强。英国宠物食品协会于2024年3月发布的《2024年宠物资料》报告显示,英国目前有1,720万户家庭饲养宠物,占家庭总数的60%。这个不断增长的消费群体正在推动提供组合疗法的市场领导的收入成长。硕腾公司在2024年11月发布的第三季财报中指出,其在美国的宠物产品销售额成长了18%,这主要得益于其Simparica Trio组合驱虫药的持续需求。
全球宠物驱虫剂市场面临的主要障碍是日益严格的环境影响和化学品安全法律规范。世界各地的监管机构正在实施更严格的通讯协定,以确保杀虫剂中的活性成分不会对当地生态系统或动物健康造成长期损害。这种加强的监管迫使製造商在推出新配方之前进行广泛且高成本的毒性测试。因此,创新驱虫剂的研发週期显着延长,产品上市时间延后,产业创新步伐也随之放缓。
这些监管合规要求造成了沉重的经济负担,并直接影响关键细分市场的盈利。面对不断增加的成本,生产商可能会犹豫是否投资新产品线,这可能导致先进害虫防治解决方案的供应停滞。这种监管负担对产业的关键领域影响尤其显着。根据美国宠物用品协会统计,2024年美国宠物用品和非处方药(包括处方笺驱虫剂)的销售额将达到320亿美元。如此庞大的市场尤其脆弱,因为符合安全标准的高成本可能会挤压利润空间,并阻碍市场成长所需的新一代驱虫剂的研发。
由于担心毒性,宠物饲主越来越倾向于避免使用合成化学品,因此对天然植物来源配方的偏好正在从根本上改变市场格局。与以往基于疾病爆发的市场驱动因素不同,这一趋势源于消费者对「洁净标示」安全性的积极需求,促使他们寻找精油为基础、有效且不会对敏感动物产生副作用的产品。这种对无毒产品日益增长的需求,推动了完全依赖植物来源活性成分的新兴品牌的快速扩张。例如,Wonderside在2024年5月宣布总部搬迁的新闻稿中指出,其植物来源害虫防治产品的销售额在过去两年增长了两倍,实现了两位数的增长,这表明消费者明显转向了安全、天然的预防性解决方案。
与此同时,直接面向消费者 (DTC) 和订阅式分销模式的兴起正在彻底改变驱虫剂的购买方式,使该行业从不规则的兽医就诊转向可靠的自动化宅配。这种结构性变革确保饲主在需要时能够可靠地接收药物,解决了持续治疗的关键难题,并实现了持续的寄生虫预防。大型零售商正在利用这一趋势,推广订阅服务以确保长期客户维繫和收入稳定。市场领导的数据清楚地展现了这一重大转变。 Chewy 于 2024 年 12 月发布的 2024 年第三季财报显示,自动出货订阅营收年增 8.7% 至 23 亿美元,凸显了订阅模式在宠物健康领域的广泛应用。
The Global Pet Insect Repellent Market is projected to expand from USD 3.41 Billion in 2025 to USD 4.45 Billion by 2031, registering a CAGR of 4.54%. These repellents consist of specialized oral or topical formulations, such as sprays, collars, and spot-on treatments, designed to protect companion animals by deterring or eradicating external parasites like mosquitoes, ticks, and fleas. A major force behind this market is the strengthening bond between humans and animals, which encourages owners to prioritize preventative healthcare to lower the risk of zoonotic vector-borne diseases. This fundamental shift toward regular wellness spending is significant; the American Pet Products Association reported that in 2024, United States expenditures on veterinary care and product sales amounted to $39.8 billion.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.41 Billion |
| Market Size 2031 | USD 4.45 Billion |
| CAGR 2026-2031 | 4.54% |
| Fastest Growing Segment | Spot-on Treatments |
| Largest Market | North America |
However, a major obstacle hindering extensive market growth is the increasingly strict regulatory environment concerning environmental safety and chemical toxicity. Manufacturers are required to navigate intricate approval procedures established by agencies that thoroughly investigate active ingredients for any negative impacts on local ecosystems and animal health. These elevated compliance standards demand comprehensive safety testing, which increases research and development expenses and postpones the commercial launch of new, compliant pest control products.
Market Driver
The rising incidence of vector-borne diseases, worsened by climate-induced expansions of pest habitats, serves as a primary engine for market growth. As rising temperatures extend the breeding seasons for mosquitoes, ticks, and fleas, pet owners are increasingly focusing on highly effective preventative measures to shield their animals from severe conditions like heartworm and Lyme disease. This growing awareness of environmental threats has led to significant revenue increases for producers of strong antiparasitic treatments. For example, Boehringer Ingelheim's April 2024 'Annual Report 2023' highlighted that sales of their flea and tick brand, NEXGARD, rose by 17.2% on a currency-adjusted basis to 1.2 billion EUR, demonstrating strong consumer dependence on reliable preventative care.
Concurrently, rising global pet ownership rates and the trend toward pet humanization are broadening the customer base for high-quality wellness products. Because owners increasingly regard companion animals as essential family members, there is higher adherence to preventative healthcare and a greater readiness to purchase advanced, user-friendly repellent formats. According to the March 2024 'Pet Population Data 2024' report by UK Pet Food, 60% of households in the United Kingdom, totaling 17.2 million homes, now own a pet. This expanding demographic drives revenue for market leaders providing combination therapies; Zoetis reported in their Q3 2024 financial results from November 2024 that U.S. sales of companion animal products rose by 18%, largely fueled by persistent demand for the Simparica Trio combination parasiticide.
Market Challenge
The principal barrier impeding the Global Pet Insect Repellent Market is the progressively stringent regulatory structure regarding environmental impact and chemical safety. Regulators worldwide are implementing tighter protocols to guarantee that active ingredients in parasiticides do not create long-term hazards for local ecosystems or animal well-being. This intensified scrutiny compels manufacturers to undertake extensive and costly toxicity testing prior to introducing new formulations. As a result, the research and development timeline for innovative repellents is notably prolonged, which delays product releases and diminishes the pace of innovation within the sector.
The economic weight of these compliance mandates is significant and directly impacts the profitability of key market segments. Producers confronting these rising costs may become reluctant to fund new product lines, leading to a stagnation in the supply of advanced pest control options. This regulatory strain disproportionately affects a vital part of the industry; the American Pet Products Association noted that in 2024, sales in the United States for supplies and over-the-counter medicines, a category encompassing non-prescription insect repellents, reached $32 billion. Such a substantial market segment is highly susceptible, as the elevated expense of satisfying safety standards can reduce margins and discourage the development of next-generation repellents necessary for market growth.
Market Trends
A growing preference for natural and plant-based formulations is fundamentally transforming the market as pet owners increasingly turn away from synthetic chemicals due to toxicity worries. Distinct from traditional drivers based on disease prevalence, this trend is motivated by a proactive demand for "clean label" safety, prompting consumers to look for essential oil-based options that offer effectiveness without the risk of adverse reactions in sensitive animals. This appetite for non-toxic remedies is fueling rapid expansion for challenger brands that rely solely on botanical actives. For example, Wondercide's May 2024 press release regarding their headquarters relocation cited double-digit growth, noting that sales for plant-based pest control items have tripled in the past two years, signaling a clear consumer pivot toward safe, nature-derived preventative solutions.
At the same time, the growth of Direct-to-Consumer and subscription-based distribution models is revolutionizing the purchase of repellents, shifting the industry from irregular veterinary visits to reliable, automated home delivery. This structural evolution resolves the crucial challenge of treatment adherence by ensuring owners receive doses precisely when required, thus sustaining continuous parasite protection. Major retailers are leveraging this trend by incentivizing recurring purchases, which guarantees long-term customer retention and stabilizes revenue. This significant shift is highlighted by market leaders; Chewy's 'Q3 2024 Earnings Results' from December 2024 reported that Autoship subscription revenue increased by 8.7% year-over-year to $2.3 billion, demonstrating the prevalence of the recurring delivery model in the pet health sector.
Report Scope
In this report, the Global Pet Insect Repellent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Pet Insect Repellent Market.
Global Pet Insect Repellent Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: